Clotting & vascular disease is a long-term risk from the "unprecedented" vaccine.
Introducing 2 new tests for post-JAB risks.
These tests include robust evaluation of your clotting status and more.
Click here or the image above to learn more about this program.
Below is information on selected post-JAB biomarkers for which you should consider determining.
Listen to Dr. Charles Hoffe discuss the importance of the D-Dimer test. It could be a life-saving measurement.
Dr. Charles Hoffe never wanted to be in the spotlight, especially for talking about the adverse health effects of the COVID vaccine. But when patients began showing up at his office with “serious injuries,” he knew he had to speak out.
Hoffe works as a family physician at Lytton Medical Clinic in British Columbia.
Dr. Liji Thomas, MD discusses "D-dimer - A sensitive novel biomarker of COVID-19 mortality"
Summary: a new study published on the preprint server medRxiv reports the use of D-dimer in predicting the risk of mortality in COVID-19.
Troponin, ESR, and CRP:
Initial laboratory evaluation showed an elevated troponin I of 14 ng/mL (normal <0.032 ng/mL), an elevated C-reactive protein (CRP) of 25 ng/mL (normal 0–0.5 ng/mL), and erythrocyte sedimentation rate (ESR) of 25 mm/h (normal <3 mm/h).
A troponin test measures the levels of troponin T or troponin I proteins in the blood. These proteins are released when the heart muscle has been damaged, such as occurs with a heart attack. The more damage there is to the heart, the greater the amount of troponin T and I there will be in the blood